BioAgilytix, a leading provider of contract bioanalytical services, has been selected by the Triangle Business Journal as a 2014 Leader in Diversity. The Leaders in Diversity Awards program is in its second year and recognizes the accomplishments of Triangle businesses, individuals, and nonprofits as they strive to reflect the rich tapestry of our community. These winners have demonstrated respect or inclusive treatment of others, advocacy for underrepresented groups and multicultural marketing.
Afshin Safavi, Ph.D., the Chief Scientific Officer & Founder of BioAgilytix, has been instrumental in developing BioAgilytix’s diverse and accepting culture. Afshin has created an atmosphere that believes in “bringing people together regardless of their skin color, gender, or religion and allowing them to use their talent to achieve their highest personal and company goals.”
As BioAgilytix continues to expand, Afshin is determined to maintain a diverse team. He sees the varying levels of expertise and life experiences on BioAgilytix’s team as critical to the company’s success and the company’s hiring practices put his belief in the importance of diversity into action. Afshin often quotes that “our IP is our people.” What he means by this is that BioAgilytix’s success is not dependent on any piece of equipment or information; instead, success and competitive differentiation is dependent on an experienced and diverse team.
About BioAgilytix www.bioagilytix.com
BioAgilytix is a leading bioanalytical testing laboratory specializing in large-molecule bioanalysis. Located in North Carolina’s Research Triangle, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assays services supporting the development and release testing of biologics and small molecule therapeutics. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, spirit-of-GLP, and GLP, as well as product release testing under GMP.
BioAgilytix’s team of highly experienced scientific and QA professionals ensures high quality science, sample and data integrity, and regulatory compliance through all phases of clinical development, acting as a trusted partner to 6 of the top 10 global pharmaceutical and biotech companies.
Matthew Hoyle, Marketing Manager